Pesquisar
Cencora Inc
CORAdicionar à lista de desejos
261.080USD
+5.550+2.17%
Fechamento 05/08, 16:00（ET）Cotações atrasadas em 15 min
50.80BValor de mercado
19.91P/L TTM
Mais detalhes de Cencora Inc Empresa
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Informações de Cencora Inc
Código da empresaCOR
Nome da EmpresaCencora Inc
Data de listagemMay 28, 1996
CEOMauch (Robert P)
Número de funcionários51000
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 28
Endereço1 West First Avenue
CidadeCONSHOHOCKEN
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal19428
Telefone16107277000
Sitehttps://www.cencora.com/
Código da empresaCOR
Data de listagemMay 28, 1996
CEOMauch (Robert P)
Executivos da empresa Cencora Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
30.71K
+22.08%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
23.57K
+20.12%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
17.62K
+3.16%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.17K
+4.58%
Mr. Pawan Verma
Mr. Pawan Verma
Executive Vice President, Chief Data and Information Officer
Executive Vice President, Chief Data and Information Officer
5.15K
+18.73%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
3.13K
+3.45%
Ms. Lori J. Ryerkerk
Ms. Lori J. Ryerkerk
Independent Director
Independent Director
1.07K
+51.91%
Dr. Lorence H. Kim, M.D.
Dr. Lorence H. Kim, M.D.
Independent Director
Independent Director
168.00
-469.64%
Mr. Franklin K. (Frank) Clyburn, Jr.
Mr. Franklin K. (Frank) Clyburn, Jr.
Independent Director
Independent Director
--
--
Mr. Francois Mandeville
Mr. Francois Mandeville
Executive Vice President - Strategy and M&A
Executive Vice President - Strategy and M&A
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
30.71K
+22.08%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
23.57K
+20.12%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
17.62K
+3.16%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.17K
+4.58%
Mr. Pawan Verma
Mr. Pawan Verma
Executive Vice President, Chief Data and Information Officer
Executive Vice President, Chief Data and Information Officer
5.15K
+18.73%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
3.13K
+3.45%
Detalhamento da receita
Os dados relevantes ainda não foram divulgados pela empresa.
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.
Distribuição de ações
Atualizado em: há 4 horas
Atualizado em: há 4 horas
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
6.60%
State Street Investment Management (US)
4.78%
Walgreens Holding Co
3.84%
T. Rowe Price Investment Management, Inc.
3.44%
T. Rowe Price Associates, Inc.
3.41%
Outro
77.93%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
6.60%
State Street Investment Management (US)
4.78%
Walgreens Holding Co
3.84%
T. Rowe Price Investment Management, Inc.
3.44%
T. Rowe Price Associates, Inc.
3.41%
Outro
77.93%
Tipos de investidores
Investidores
Proporção
Investment Advisor
56.73%
Investment Advisor/Hedge Fund
28.30%
Corporation
3.84%
Research Firm
3.04%
Pension Fund
2.35%
Bank and Trust
2.21%
Hedge Fund
2.09%
Sovereign Wealth Fund
1.31%
Family Office
1.17%
Participação acionária institucional
Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
2508
188.32M
96.79%
+947.64K
2025Q4
2325
185.17M
94.90%
+31.68K
2025Q3
2360
185.31M
95.09%
+4.64M
2025Q2
2343
180.65M
95.85%
-533.00K
2025Q1
2278
180.99M
94.03%
-1.15M
2024Q4
2205
177.00M
96.12%
-3.08M
2024Q3
2114
179.91M
93.30%
+3.58M
2024Q2
2070
176.04M
91.35%
-1.09M
2024Q1
2048
176.18M
88.49%
-350.13K
2023Q4
1964
171.90M
85.06%
+6.01M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
12.84M
6.6%
+27.28K
+0.21%
Dec 31, 2025
State Street Investment Management (US)
9.31M
4.78%
+115.19K
+1.25%
Dec 31, 2025
Walgreens Holding Co
7.47M
3.84%
-2.91M
-28.01%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
6.70M
3.44%
+4.12M
+160.07%
Dec 31, 2025
T. Rowe Price Associates, Inc.
6.63M
3.41%
-725.19K
-9.87%
Dec 31, 2025
Geode Capital Management, L.L.C.
5.46M
2.81%
+169.06K
+3.20%
Dec 31, 2025
Fidelity Management & Research Company LLC
5.12M
2.63%
+2.18M
+73.88%
Dec 31, 2025
Wellington Management Company, LLP
4.54M
2.33%
+564.87K
+14.22%
Dec 31, 2025
JP Morgan Asset Management
4.44M
2.28%
+703.18K
+18.80%
Dec 31, 2025
Boston Partners
4.20M
2.16%
-312.63K
-6.93%
Dec 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
VanEck Pharmaceutical ETF
8.42%
AdvisorShares Focused Equity ETF
5.56%
First Trust Consumer Staples Alphadex Fund
3.52%
Goldman Sachs Future Health Care Equity ETF
3.48%
VanEck Retail ETF
3.31%
Hennessy Sustainable ETF
3.08%
iShares US Consumer Staples ETF
3.02%
American Century Mid Cap Growth Impact ETF
2.66%
SEI Enhanced US Large Cap Momentum Factor ETF
2.51%
Counterpoint Quantitative Equity ETF
2.4%
Ver Mais
VanEck Pharmaceutical ETF
Proporção8.42%
AdvisorShares Focused Equity ETF
Proporção5.56%
First Trust Consumer Staples Alphadex Fund
Proporção3.52%
Goldman Sachs Future Health Care Equity ETF
Proporção3.48%
VanEck Retail ETF
Proporção3.31%
Hennessy Sustainable ETF
Proporção3.08%
iShares US Consumer Staples ETF
Proporção3.02%
American Century Mid Cap Growth Impact ETF
Proporção2.66%
SEI Enhanced US Large Cap Momentum Factor ETF
Proporção2.51%
Counterpoint Quantitative Equity ETF
Proporção2.4%
Dividendo
Um total de
2.01B
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
May 06, 2026
COR.NB Interim Cash Dividend of gross USD 0.6 paid on Jun 01, 2026 going ex on May 15, 2026
May 15, 2026
Jun 01, 2026
May 15, 2026
Feb 04, 2026
COR.NB Interim Cash Dividend of gross USD 0.6 paid on Mar 02, 2026 going ex on Feb 13, 2026
Feb 13, 2026
Mar 02, 2026
Feb 13, 2026
Nov 04, 2025
COR.NB Final Cash Dividend of gross USD 0.6 paid on Dec 01, 2025 going ex on Nov 14, 2025
Nov 14, 2025
Dec 01, 2025
Nov 14, 2025
Aug 06, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Sep 03, 2025 going ex on Aug 15, 2025
Aug 15, 2025
Sep 03, 2025
Aug 15, 2025
May 07, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Jun 02, 2025 going ex on May 16, 2025
May 16, 2025
Jun 02, 2025
May 16, 2025
Feb 05, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Mar 03, 2025 going ex on Feb 14, 2025
Feb 14, 2025
Mar 03, 2025
Feb 14, 2025
Nov 06, 2024
COR.NB Final Cash Dividend of gross USD 0.55 paid on Nov 29, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Nov 29, 2024
Nov 15, 2024
Jul 31, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 26, 2024 going ex on Aug 09, 2024
Aug 09, 2024
Aug 26, 2024
Aug 09, 2024
May 01, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on May 24, 2024 going ex on May 09, 2024
May 10, 2024
May 24, 2024
May 09, 2024
Jan 31, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 26, 2024 going ex on Feb 08, 2024
Feb 09, 2024
Feb 26, 2024
Feb 08, 2024
Ver Mais
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
